Church & Dwight Raises Sales Outlook Following Strong Quarterly Results

Church & Dwight Co., Inc. recently delivered better-than-expected quarterly results, driven by higher product volumes across its core household and personal care brands. Net revenue rose 1.0% year over year to $1.60 billion, ahead of the $1.58 billion anticipated by analysts and surpassing management's earlier guidance that had called for a slight decline. The company reported adjusted earnings per share of $0.92, topping consensus estimates of $0.90 and climbing from $0.81 in the prior-year period.

Organic sales growth came predominantly from volume increases rather than pricing actions, a pattern that contrasted with recent broader industry trends. Growth was supported by key labels including Arm & Hammer liquid laundry detergent and cat litter, OxiClean Max Force, and TheraBreath, alongside contributions from Hero, Waterpik, and Batiste. Gross margin widened as pricing, productivity gains, and a positive product mix counteracted pressure from freight and commodity expenses.

Following the performance, management raised its full-year net sales projection and nudged its organic sales expectations higher. The company also narrowed its full-year adjusted earnings growth forecast toward the firmer end of its prior range, while keeping its full-year cash generation target unchanged. In addition, the board approved a new, open-ended share repurchase authorization to replace its former plan, giving leadership ongoing flexibility to retire stock over time.

The company also declared a quarterly dividend of $0.3075 per share, representing an annualized rate of $1.23 and a yield of 1.1%. The dividend is scheduled for payment on Tuesday, December 1st, to stockholders of record on Friday, November 13th.

Brokerages tracked by MarketBeat maintain a consensus rating of Hold on the shares, consisting of eight Buy, eight Hold, and one Sell recommendation, alongside an average price objective of $108.44. In recent adjustments, Oppenheimer boosted its price target from $115.00 to $120.00 with an outperform rating, while Morgan Stanley lifted its target from $112.00 to $117.00 with an equal weight rating. Filings show corporate insiders sold 141,390 shares totaling $15,252,844 over the past three months, including a sale of 83,340 shares by Chief Executive Officer Richard A. Dierker on Tuesday, November 3rd.